Double 6/18-month Phase III study to reproduce symptomatic and potentially show disease-modifying efficacy of buntanetap in treating Alzheimer&#39;s disease

Posiphen (buntanetap) - Annovis Bio

Maria MACCECCHINI 1; Cheng FANG 1; Melissa GAINES 1; Sarah MACALLUM 1; Daniel LASKOWITZ 2; Martin FARLOW 3

Dec 14, 2025